| Passive stiffness of myocardium from congenital heart disease and implications for diastole RR Chaturvedi, T Herron, R Simmons, D Shore, P Kumar, B Sethia, ... Circulation 121 (8), 979-988, 2010 | 208 | 2010 |
| Organ donation in the US and Europe: The supply vs demand imbalance A Lewis, A Koukoura, GI Tsianos, AA Gargavanis, AA Nielsen, ... Transplantation Reviews 35 (2), 100585, 2021 | 184 | 2021 |
| MMP mediated degradation of type VI collagen is highly associated with liver fibrosis–identification and validation of a novel biochemical marker assay SS Veidal, MA Karsdal, E Vassiliadis, A Nawrocki, MR Larsen, ... PloS one 6 (9), e24753, 2011 | 176 | 2011 |
| Novel combinations of post-translational modification (PTM) neo-epitopes provide tissue-specific biochemical markers—are they the cause or the consequence of the disease? MA Karsdal, K Henriksen, DJ Leeming, T Woodworth, E Vassiliadis, ... Clinical biochemistry 43 (10-11), 793-804, 2010 | 171 | 2010 |
| Characterisation of age-dependent beta cell dynamics in the male db/db mice LS Dalbøge, DLC Almholt, TSR Neerup, E Vassiliadis, N Vrang, ... PloS one 8 (12), e82813, 2013 | 107 | 2013 |
| Enzyme‐linked immunosorbent serum assay specific for the 7S domain of collagen type IV (P4NP 7S): a marker related to the extracellular matrix remodeling during liver fibrogenesis DJ Leeming, MJ Nielsen, Y Dai, SS Veidal, E Vassiliadis, C Zhang, Y He, ... Hepatology Research 42 (5), 482-493, 2012 | 106 | 2012 |
| Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats SS Veidal, E Vassiliadis, AC Bay-Jensen, G Tougas, B Vainer, ... Fibrogenesis & tissue repair 3, 1-7, 2010 | 88 | 2010 |
| Post-translational modifications of the extracellular matrix are key events in cancer progression: opportunities for biochemical marker development DJ Leeming, AC Bay-Jensen, E Vassiliadis, MR Larsen, K Henriksen, ... Biomarkers 16 (3), 193-205, 2011 | 86 | 2011 |
| Circulating levels of citrullinated and MMP-degraded vimentin (VICM) in liver fibrosis related pathology E Vassiliadis, CP Oliveira, MR Alvares-da-Silva, C Zhang, FJ Carrilho, ... American journal of translational research 4 (4), 403, 2012 | 78 | 2012 |
| Circulating citrullinated vimentin fragments reflect disease burden in ankylosing spondylitis and have prognostic capacity for radiographic progression AC Bay‐Jensen, MA Karsdal, E Vassiliadis, S Wichuk, ... Arthritis & Rheumatism 65 (4), 972-980, 2013 | 73 | 2013 |
| Matrix metalloproteinase‐9‐mediated type III collagen degradation as a novel serological biochemical marker for liver fibrogenesis SS Veidal, E Vassiliadis, N Barascuk, C Zhang, T Segovia‐Silvestre, ... Liver International 30 (9), 1293-1304, 2010 | 72 | 2010 |
| Immunological detection of the type V collagen propeptide fragment, PVCP-1230, in connective tissue remodeling associated with liver fibrosis E Vassiliadis, SS Veidal, H Simonsen, DV Larsen, B Vainer, X Chen, ... Biomarkers 16 (5), 426-433, 2011 | 59 | 2011 |
| Measurement of CO3-610, a potential liver biomarker derived from matrix metalloproteinase-9 degradation of collagen type iii, in a rat model of reversible carbon-tetrachloride … E Vassiliadis, D Vang Larsen, RE Clausen, SS Veidal, N Barascuk, ... Biomarker Insights 6, BMI. S6347, 2011 | 59 | 2011 |
| Novel cardiac-specific biomarkers and the cardiovascular continuum E Vassiliadis, N Barascuk, A Didangelos, MA Karsdal Biomarker Insights 7, BMI. S9536, 2012 | 58 | 2012 |
| Impact of design on medical device safety T Miclăuş, V Valla, A Koukoura, AA Nielsen, B Dahlerup, GI Tsianos, ... Therapeutic Innovation & Regulatory Science 54 (4), 839-849, 2020 | 43 | 2020 |
| Measurement of matrix metalloproteinase 9-mediated collagen type III degradation fragment as a marker of skin fibrosis E Vassiliadis, SS Veidal, N Barascuk, JB Mullick, RE Clausen, L Larsen, ... BMC dermatology 11, 1-7, 2011 | 40 | 2011 |
| Development and validation of an enzyme-linked immunosorbent assay for the quantification of a specific MMP-9 mediated degradation fragment of type III collagen—A novel … N Barascuk, E Vassiliadis, L Larsen, J Wang, Q Zheng, R Xing, Y Cao, ... Clinical biochemistry 44 (10-11), 900-906, 2011 | 40 | 2011 |
| Circulating CO3-610, a degradation product of collagen III, closely reflects liver collagen and portal pressure in rats with fibrosis T Segovia-Silvestre, V Reichenbach, G Fernández-Varo, E Vassiliadis, ... Fibrogenesis & Tissue Repair 4, 1-10, 2011 | 37 | 2011 |
| The effect of ileal interposition surgery on enteroendocrine cell numbers in the UC Davis type 2 diabetes mellitus rat CF Hansen, E Vassiliadis, N Vrang, PT Sangild, BP Cummings, P Havel, ... Regulatory peptides 189, 31-39, 2014 | 28 | 2014 |
| Clinical evaluation of a matrix metalloproteinase-12 cleaved fragment of titin as a cardiovascular serological biomarker E Vassiliadis, LM Rasmussen, I Byrjalsen, DV Larsen, R Chaturvedi, ... Journal of translational medicine 10, 1-10, 2012 | 24 | 2012 |
